Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice

被引：32

作者：

Hagtvet, Eirik ^{[2
,3
]}

Evjen, Tove J. ^{[4
,5
]}

Olsen, Dag Rune ^{[1
]}

Fossheim, Sigrid L. ^{[4
]}

Nilssen, Esben A.

机构：

[1] Univ Bergen, Fac Math & Nat Sci, N-5020 Bergen, Norway

[2] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway

[3] Univ Oslo, Oslo, Norway

[4] Epitarget AS, Oslo, Norway

[5] Univ Tromso, Fac Hlth Sci, Dept Pharm, Drug Transport & Delivery Grp, Tromso, Norway

来源：

JOURNAL OF DRUG TARGETING | 2011年 / 19卷 / 08期

关键词：

Therapeutic effect; low frequency ultrasound; drug delivery; drug release; STERICALLY STABILIZED LIPOSOMES; DRUG-DELIVERY; CARDIAC SAFETY; PHARMACOKINETICS; RELEASE; THRESHOLDS; TOXICITY;

D O I：

10.3109/1061186X.2010.551401

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Liposomal encapsulation of doxorubicin (DXR) improves tumor accumulation and reduces adverse effects. One possible strategy for further optimization of this delivery technology would be to design the liposome carrier to release its content within the tumor tissue in response to specific stimuli such as ultrasound (US). In this study, the tumor uptake properties and therapeutic efficacy of 1,2 distearoyl-sn-glycero-3-phosphatidylethanolamine-based liposomes containing DXR were investigated in nude mice bearing tumor xenografts. The liposomal DXR formulation alone showed no inhibitory effect on tumor growth. However, upon exposure to low frequency US in situ inhibition of tumor growth was demonstrated.

引用

页码：701 / 708

页数：8

共 50 条

[31] Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing [J].

Ngoune, Romeo ;

Contini, Christine ;

Hoffmann, Michael M. ;

von Elverfeldt, Dominik ;

Winkler, Karl ;

Puetz, Gerhard .

CURRENT DRUG DELIVERY, 2018, 15 (09) :1261-1270

[32] Enhanced In Vivo Antitumor Efficacy of Doxorubicin Encapsulated within Laponite Nanodisks [J].

Li, Kai ;

Wang, Shige ;

Wen, Shihui ;

Tang, Yueqin ;

Li, Jipeng ;

Shi, Xiangyang ;

Zhao, Qinghua .

ACS APPLIED MATERIALS & INTERFACES, 2014, 6 (15) :12328-12334

[33] Development and Characterization of Liposomal Doxorubicin Hydrochloride with Palm Oil [J].

Sabeti, Bahareh ;

Noordin, Mohamed Ibrahim ;

Mohd, Shaharuddin ;

Hashim, Rosnani ;

Dahlan, Afendi ;

Javar, Hamid Akbari .

BIOMED RESEARCH INTERNATIONAL, 2014, 2014

[34] Deeper Penetration into Tumor Tissues and Enhanced in Vivo Antitumor Activity of Liposomal Paclitaxel by Pretreatment with Angiogenesis Inhibitor SU5416 [J].

Yoshizawa, Yuta ;

Ogawara, Ken-ichi ;

Fushimi, Aya ;

Abe, Shigeki ;

Ishikawa, Keisuke ;

Araki, Tomoya ;

Molema, Grietje ;

Kimura, Toshikiro ;

Higaki, Kazutaka .

MOLECULAR PHARMACEUTICS, 2012, 9 (12) :3486-3494

[35] In vitro and in vivo Antitumor Activity of Doxorubicin-Loaded Alginic-Acid-Based Nanoparticles [J].

Cheng, Yuan ;

Yu, Shuling ;

Wang, Jingjing ;

Qian, Hanqing ;

Wu, Wei ;

Jiang, Xiqun .

MACROMOLECULAR BIOSCIENCE, 2012, 12 (10) :1326-1335

[36] Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice [J].

Kurihara, A ;

Shibayama, Y ;

Mizota, A ;

Yasuno, A ;

Ikeda, M ;

Sasagawa, K ;

Kobayashi, T ;

Hisaoka, M .

PHARMACEUTICAL RESEARCH, 1996, 13 (02) :305-310

[37] Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas [J].

Amin, Mohamadreza ;

Badiee, Ali ;

Jaafari, Mahmoud Reza .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 458 (02) :324-333

[38] The role of size in PEGylated liposomal doxorubicin biodistribution and anti-tumour activity [J].

Dadpour, Saba ;

Mehrabian, Amin ;

Arabsalmani, Mahdieh ;

Mirhadi, Elaheh ;

Askarizadeh, Anis ;

Mashreghi, Mohammad ;

Jaafari, Mahmoud Reza .

IET NANOBIOTECHNOLOGY, 2022, 16 (7-8) :259-272

[39] A pegylated liposomal platform: Pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug [J].

Lu, WL ;

Qi, XR ;

Zhang, Q ;

Li, RY ;

Wang, GL ;

Zhang, RJ ;

Wei, SL .

JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 95 (03) :381-389

[40] Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study [J].

Cabeza, Laura ;

Ortiz, Raul ;

Prados, Jose ;

Delgado, Angel V. ;

Martin-Villena, Maria J. ;

Clares, Beatriz ;

Perazzoli, Gloria ;

Entrena, Jose M. ;

Melguizo, Consolacion ;

Arias, Jose L. .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 102 :24-34

← 1 2 3 4 5 →